Category: Partner news

AllerGen researchers recognized for excellence by CSACI

Four AllerGen investigators were recently recognized with awards by the Canadian Society of Allergy and Clinical Immunology (CSACI) at that organization’s 2017 Annual Scientific Meeting. Dr. Susan Waserman was named the inaugural recipient of the Milton Gold Memorial Lectureship, “presented

Allergy Pals going strong

On August 11, 2017, student Benjamin Cruickshank and his mom, Allison, met with AllerGen staff to share how the Allergy Pals program for kids with food allergies has had an impact on their lives. “I love Allergy Pals,” says 11-year-old

Food Allergy Canada takes lead in McDonald’s menu controversy

Changes at one of the country’s oldest fast-food franchises have sparked controversy around food allergens and restaurant policies. McDonald’s Canada recently announced that all food products sold in its restaurants “may contain peanuts, tree nuts or other allergens” as the

Randy Yatscoff wins lifetime achievement award for Canadian entrepreneurship

Dr. Randy Yatscoff, a key member of the AllerGen network since 2010, has been awarded the Startup Canada Adam Chowaniec Lifetime Achievement Award. The award is presented to an individual who has demonstrated an “outstanding impact and enduring legacy” in

AllerGen investigators honoured by CSACI

Two AllerGen investigators were honoured at the Awards Dinner of the 2016 Canadian Society of Allergy and Clinical Immunology (CSACI) Annual Scientific Meeting held September 29 – October 2, 2016, in Montreal, QC. Dr. Bruce Mazer (McGill University) received the

AllerGen partner launches new anaphylaxis training course

Food Allergy Canada—the community-based advocacy, information, education and research organization and valued AllerGen partner—has launched a new online training course for parents and caregivers entitled: “Anaphylaxis in the Community: What Parents and Others Need to Know.” Developed with Leap Learning Technologies

AllerGen speakers featured at AQIA Annual Meeting

AllerGen Scientific Director Dr. Judah Denburg and research leader Dr. Susan Elliott were among the presenters featured at the 6th Annual Meeting of (AQIA), held 30 September 2015 in Quebec City. The theme of the meeting was “Food Allergen Management:

New report on Canadian anaphylaxis and allergic reactions in the emergency department

How many Canadians visit emergency departments (ED) each year due to allergic reactions and anaphylaxis? Are the numbers growing? Which months are the most common for anaphylactic emergencies? How have prescription patterns for epinephrine auto-injectors changed over time? A new

AllerGen researchers appointed to Hydra Biosciences Advisory Board

AllerGen research leader Dr. Paul O’Byrne has been appointed to the newly created Pulmonary Medical Advisory Board of Hydra Biosciences, a Massachusetts-based biopharmaceutical company that develops drugs to treat pain, inflammation, renal disease, anxiety and pulmonary disease. Dr. O’Byrne, a

AllerGen researcher Dr. Kelly McNagny named Co-Scientific Director of CDRD

Dr. Kelly McNagny has been named a Co-Scientific Director of the Centre for Drug Research and Development (CDRD)—a national not-for-profit that speeds the development and commercialization of new drugs and health technologies emerging from Canada’s universities and research hospitals. Dr.

Canadian allergists recommend early peanut introduction for “high risk” infants

A new consensus communication—issued jointly by Canadian, American and European allergists and the World Allergy Organization—recommends introducing peanut-containing products into the diet of “high risk” infants between four and 11 months of age. The Canadian Society of Allergy & Clinical

“Clearing the Air” on World Asthma Day

AllerGen partner organization the Asthma Society of Canada is holding the event “Clearing the Air: Asthma and Allergies in a Time of Climate Change” on May 4 and 5, 2015, in Toronto, ON, to coincide with World Asthma Day. Motivated